DCO

Analyst Note: Ducommun Incorporated (DCO)

Date: June 13, 2026 Sector: Industrials (Aerospace & Defense)

1. Structural Readiness

• Conservative Entry: $105.58.
• Current Price: $164.12.
• Extension: The stock is currently extended +55.4% above the conservative entry point.
• Breakout Level: The breakout occurred at the consolidation boundary, now serving as the floor for the active trend.
• Volatility Context: At the time of the breakout, the ATR was 2.9% (productive). Current ATR is 3.9% (productive). The volatility remains within the "productive" structural quality range, indicating healthy trend participation without extreme erraticism.

2. Thesis Layer

The primary secular thesis driving this setup is Defense Modernization, specifically within the Precision Munitions sub-sector.

• Primary Exposure: DCO is a direct beneficiary of the "Precision Munitions" wave. The company is a key supplier for over a dozen missile platforms, including the PAC-3, SM-3, SM-6, Tomahawk, and RAM.
• Thesis Strength: The evidence indicates a "high confidence" tier-2 exposure. Management explicitly states that production on these specific programs is expected to "grow severalfold," positioning DCO as a critical enabler of the U.S. defense industrial base's ramp-up.
• Secondary Exposure: While the primary driver is defense, the company also benefits from Commercial Aerospace Recovery. The FAA's clearance of Boeing's 737 MAX production increase (from 38 to 42 units/month) provides a secondary tailwind, though the defense thesis carries the conviction weight for this specific price action.

3. Business Overview

Ducommun Incorporated operates as a specialized manufacturer of advanced engineering and manufacturing solutions, divided into two principal segments: Electronic Systems and Structural Systems.

• Electronic Systems: This division produces sophisticated components including cable assemblies, wire harnesses, interconnect systems, printed circuit board assemblies, and complex electromechanical sub-assemblies. They also provide critical defense-specific hardware such as lightning diversion systems, radar housings, and high-frequency microwave switches.
• Structural Systems: This segment manufactures precision-engineered components from aluminum, titanium, and Inconel alloys. Their output includes complete structural assemblies like winglets, engine components, and fuselage panels.

Financial & Operational Evidence (as of May 12, 2026):

• Backlog Strength: The company reported Remaining Performance Obligations (RPO) of $1.1 billion as of Q1 2026, an increase of $86 million year-over-year. The backlog stood at $1,202.9 million at year-end 2025, up from $1,060.8 million in 2024.
• Revenue Growth: Net revenues for the three months ended April 4, 2026, reached $209.0 million, up from $192.5 million in the prior year period.
• Profitability: Adjusted EBITDA for the quarter was $35.4 million, representing 16.9% of net revenues. This is a significant step toward the company's "Vision 2027" goal of 18% EBITDA margins.
• Customer Concentration: The top two customers, Boeing and RTX Corporation, accounted for 13% and 18% of 2025 net revenues, respectively. Military and space end-use markets represented 58% of total revenues in 2025, while commercial aerospace represented 38%.

4. Archetype and Conviction

Archetype: Margin Inflector.

The setup fits the "Margin Inflector" archetype because the company is executing a facility consolidation program that is delivering cost savings on track for a $13 million run-rate by the end of 2026. This operational leverage is directly translating into margin expansion, evidenced by the jump in Adjusted EBITDA margin to 16.9% in Q1 2026, approaching the 18% target.

Conviction Stack:

• Thesis Strength: High. The defense modernization cycle is not a rumor; it is backed by specific program ramp-ups (Tomahawk, PAC-3, SM-6) confirmed by management.
• Evidence Quality: Strong. The evidence base is robust, citing specific RPO figures, backlog growth, and margin expansion in recent earnings transcripts and 10-K/10-Q filings.
• Structural Quality: The ATR at breakout (2.9%) and current ATR (3.9%) indicate a "productive" volatility environment, suggesting the trend is supported by genuine volume and interest rather than thin speculation.
• Rerating Potential: The combination of a growing backlog ($1.1B+), expanding margins (16.9% vs 13% in 2022), and a clear path to 18% EBITDA supports a valuation rerating as the market prices in the "Vision 2027" execution.

5. Invalidations, Strengtheners, and Gaps

Invalidation Triggers:

• A significant reduction in the RPO or backlog figures in subsequent quarters, indicating a slowdown in defense spending or customer order cancellations.
• Failure to meet the $13 million cost-saving target by end-of-2026, which would stall the margin inflection thesis.

Strengtheners:

• Confirmation of further production ramp-ups on the specific missile programs (PAC-3, SM-6) beyond the "severalfold" guidance.
• Achievement of the 18% EBITDA margin target ahead of the 2027 deadline.
• Continued growth in the commercial aerospace segment driven by the 737 MAX production increase.

Evidence Gaps:

• Missing Evidence: There is no specific evidence in the provided dataset regarding the *current* quarter's (Q2 2026) specific order intake or backlog changes as of June 13, 2026. The most recent data is from the Q1 2026 earnings call (May 12, 2026).
• Missing Evidence: No specific guidance on the *timing* of the $13 million savings realization beyond "by the end of 2026."
• Missing Evidence: No detailed breakdown of the "Electronic Systems" vs. "Structural Systems" revenue split for the most recent quarter, though the aggregate is clear.

PRIVATE ANALYST CALL

Judgment: Buy Confidence: High Key evidence: RPO at $1.1 billion with $86 million YoY growth; Adjusted EBITDA margin at 16.9% approaching 18% Vision 2027 target; confirmed production ramp on key missile programs (PAC-3, SM-6, Tomahawk). Key risks: Execution risk on facility consolidation cost savings; customer concentration risk with Boeing and RTX; potential supply chain disruptions affecting delivery schedules. Sizing hint: Position size should account for the 55% extension; consider scaling in on pullbacks to the breakout zone rather than chasing the current price. Expected path: Management expects continued revenue growth driven by defense backlog recognition and margin expansion as cost savings materialize, supporting a higher valuation multiple. Expected horizon: 12 to 18 months for the margin inflection thesis to fully play out as Vision 2027 targets are met. Failure mode to watch: A sustained decline in RPO or a miss on the $13 million cost-saving target, which would break the margin inflection narrative.